Table 1.
Demographics and laboratory findings of groups
| NAFLD group (N = 64) | Control group (N = 20) | P | |
|---|---|---|---|
| Age (mean) | 44.03 ± 10.81 | 40.05 ± 5.80 | 0.120 |
| Gender (female/male) | 36/28 | 11/9 | 0.922 |
| BMI (kg/m2) | 30.96 ± 5.65 | 25.47 ± 3.38 | 0.001 |
| Triglyceride (mg/dL) | 296.95 ± 105.25 | 155.35 ± 22.92 | 0.001 |
| Cholesterol (mg/dL) | 257.09 ± 57.19 | 160.95 ± 20.41 | 0.001 |
| LDL cholesterol (mg/dL) | 159.22 ± 37.11 | 89.05 ± 18.73 | 0.001 |
| HDL cholesterol (mg/dL) | 35.89 ± 6.37 | 40.90 ± 2.69 | 0.001 |
| Glucose (mg/dL) | 91.96 ± 9.04 | 83.65 ± 8.13 | 0.001 |
| AST (IU/L) | 65.93 ± 25.00 | 31.30 ± 6.15 | 0.001 |
| ALT (IU/L) | 84.59 ± 29.11 | 32.50 ± 6.46 | 0.001 |
| Insulin (mU) | 14.05 ± 4.59 | 8.30 ± 1.69 | 0.001 |
| HOMA-IR | 3.19 ± 1.12 | 1.71 ± 0.39 | 0.001 |
| α-Fetoprotein (ng/mL) | 4.09 ± 1.68 | 2.95 ± 1.41 | 0.008 |
BMI body mass index, AST aspartate aminotransferase, ALT alanine aminotransferase, HOMA-IR homeostasis model assessment-estimated insulin resistance, NAFLD nonalcoholic fatty liver disease